In addition, clinical studies have shown an increase in IDO in HCC tissues [24] and an elevation of the Treg population in both the periphery and tumor-infiltrating lymphocytes in patients with HCC [41, 42]. The gene discussed is IDO1; the disease is hepatocellular carcinoma.